The Board of Directors of ITL understands, promotes and is responsible for good corporate governance within the consolidated entity comprising the Company and its controlled entities.

Mr Andrews’ commercial background includes over twenty years experience in the medical devices arena where he has successfully marketed a broad range of technologies ranging from in vitro diagnostics to high technology capital equipment. During his career Mr Andrews has held a number of senior sales, marketing and operational roles encompassing sales and sales management, product and marketing management, new product development and the global commercialisation of new products and technologies. Among the highlights of his career Mr Andrews lived and worked in the United States and the United Kingdom where he led multidisciplinary teams in the development and commercialisation of market leading brands for ConvaTec, a former division of Bristol- Myers Squibb.
Mr Andrews holds the degrees of Bachelor of Science, Bachelor of Business, majoring in marketing, and a MBA from Monash University.
Interest in Shares and Options
Shares: Nil
Options: 1,000,000

Board member since 2003, appointed Chairman 1 January 2005. Mr Gosse has extensive experience in banking and broking both in Australia and overseas, having worked in London for Rowe and Pitman, in the United States for Janney Montgomery and Scott and in Canada for Wood Gundy.
He is a non-executive Director of: Australian Leaders Fund Limited since 2003; Wilson Investment Fund Limited since 2003; Clime Capital Limited since 2003; and Iron Road since March 2009 (Chairman). During the past three years was a Director of: Mariner Wealth Limited to 2006; Northern Crest Investment Limited since March 2006 and Chairman since November 2006 (Resigned 2008)
Special Responsibilities: Member of Audit and Risk Management Committee
Interest in Shares and Options
Shares: 1,050,000
Options: Nil

Board member since 1 September 2005. Mr Rose is a chemist and has 30 years experience specialising in general management, operations/production management, international sales and marketing, technology management and corporate governance within many roles at Orica Limited (formally ICI Australia).
He is Chair of the CSIRO Future Manufacturing Flagship Advisory Committee, a past President of the Australasian Industrial Research Group He is a non-executive Director of: Ceramic Fuel Cells Ltd
From April 2007 to September 2007 was an executive director acting as General Manager of ITL Healthcare Pty Ltd, a wholly owned subsidiary of ITL Limited, and from October 2008 to January 2009 was an executive director acting as Chief Executive Officer of ITL Limited.
Qualifications: Bachelor of Science (Chemistry), Member of Australian Institute of Company Directors
Special Responsibilities: Chair of Audit and Risk Management Committee
Interest in Shares and Options
Shares: 650,544
Options: Nil

Mike has a 30 year career of founding, building, managing and investing in technology companies. These include Cochlear in which he was a founder and CEO and Resmed in which he was a founding Director. Mike has significant international management expertise in all operational areas from manufacturing to research and development, intellectual property, worldwide marketing and sales, regulatory affairs, government relations, business development and developing strategic alliances with major multinationals. In 1988 he won BRW Businessman of the Year (Technology) for establishing Cochlear in the US Europe and Japan and in 2004 Mike was awarded an Order of Australia Medal for his work in commercialising medical technology.
He is a non executive director of: Biotron Limited; TGR Bio Sciences Pty Ltd; Four Hats Capital Pty Ltd; VKardia Pty Ltd and Dynamic Hearing Pty Ltd.
Qualifications: M.B.A (Macq.) M.B., B.S (Melb.) FFin
Interest in Shares and Options
Shares: Nil
Options: Nil

Jennine joined ITL in March 2009, prior to which she was with Eyecare Partners, responsible for acquisition integration and management of services provided to optometry practices in the group. Jennine also held the role of Company Secretary with Eyecare Partners for a period of 6 months.
Qualifications: Certificate in Governance Practice and Administration
Interest in Shares and Options
Shares: Nil
Options: Nil